MedPath

ROCURONIUM BROMIDE INJECTION

ROCURONIUM BROMIDE INJECTION

Approved
DIN Number

02529831

Drug Class

Human

Market Date

Feb 26, 2024

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02529831
AIG Number0126317001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M03AC09 ROCURONIUM BROMIDE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification12:20.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

ROCURONIUM BROMIDEActive
Strength: 10 MG / ML
Monograph: ROCURONIUM BROMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.